Molecular formula: | C25H28N2O4Si |
Average mass: | 448.595 |
Monoisotopic mass: | 448.181834 |
ChemSpider ID: | 130651 |
1 of 1 defined stereocentres
(4S)-4-Ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]chinolin-3,14(4H,12H)-dion
[German]
[ACD/IUPAC Name](4S)-4-Éthyl-4-hydroxy-11-[2-(triméthylsilyl)éthyl]-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoléine-3,14(4H,12H)-dione
[French]
[ACD/IUPAC Name](4S)-4-Ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
[ACD/IUPAC Name]1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-, (4S)-
[ACD/Index Name]203923-89-1
[RN]24R60NVC41
[UNII]cositecan
[INN] [USAN]cositécan
[French]
[INN]cositecán
[Spanish]
[INN]cositecanum
[Latin]
[INN]Karenitecin
[Trade name](19S)-19-ethyl-19-hydroxy-10-(2-trimethylsilylethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
(19S)-19-ethyl-19-hydroxy-10-[2-(trimethylsilyl)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
(19S)-19-ethyl-19-hydroxy-10-[2-(trimethylsilyl)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
(S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
(S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
1H-Pyrano(3′,4′:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-, (4S)-
7-Trimethylsilylethylcamptothecin
cositécan
cositecán
cositecanum
Karenitecin (Cositecan)
MFCD09833216
[MDL number]козитекан
[Russian]كوسيتيكان
[Arabic]可司替康
[Chinese]